Syringe

Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall

Retrieved on: 
Thursday, February 22, 2024

These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of the feeding tube.

Key Points: 
  • These kits include Nurse Assist supplied syringes, pre-filled with sterile water, essential for inflating the retention balloon of the feeding tube.
  • The Nurse Assist voluntary recall was initiated due to concerns about the potential lack of sterility assurance in these water-based products.
  • This deficiency may lead to non-sterile products, posing a risk of the water coming into contact with a patient's surgical site.
  • The pre-filled syringe is the only item in the Avanos feeding tube kit affected by the Nurse Assist recall.

Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems

Retrieved on: 
Friday, February 16, 2024

Sharps Technology specializes in the development and manufacturing of innovative drug delivery systems.

Key Points: 
  • Sharps Technology specializes in the development and manufacturing of innovative drug delivery systems.
  • These features protect frontline healthcare workers from life-threatening needle stick injuries and protect the public from the dangers of needle re-use.
  • Their SafeR Retractable Safety Syringe and needles offer a passive safety system with auto-disable reuse prevention features.
  • Additionally, as a Contract Development and Manufacturing Organization (CDMO), they also provide end-to-end services from design to finished products of innovative, safer medical drug delivery solutions.

INCOG BioPharma Services adds 100 million units of syringe/cartridge capacity

Retrieved on: 
Thursday, February 15, 2024

FISHERS, Ind., Feb. 15, 2024 /PRNewswire/ -- INCOG BioPharma Services, a US-based contract development and manufacturing organization (CDMO) specializing in sterile injectables, is adding a high-speed OPTIMA filling line that will provide an additional 100 million units of syringe and cartridge filling capacity.

Key Points: 
  • FISHERS, Ind., Feb. 15, 2024 /PRNewswire/ -- INCOG BioPharma Services, a US-based contract development and manufacturing organization (CDMO) specializing in sterile injectables, is adding a high-speed OPTIMA filling line that will provide an additional 100 million units of syringe and cartridge filling capacity.
  • It will complement the company's existing multi-use filling line, bringing the company's total filling capacity to 140 million units per year.
  • In addition to the new filling line, INCOG recently added automated visual inspection capabilities and will soon complete qualification of equipment to support auto-injector device assembly services.
  • The decision to increase capacity, well before current capacity limits were reached, was based on a business philosophy that prioritizes customer needs.

Medical Plastics Market Analysis Reveals Expanding Applications and Technological Advances Through 2028 - ResearchAndMarkets.com

Retrieved on: 
Monday, February 12, 2024

In 2022, the global market for medical plastics was dominated by the North American region.

Key Points: 
  • In 2022, the global market for medical plastics was dominated by the North American region.
  • North America holds a 42.3% share of the global medical plastics market.
  • The base year considered for analysis is 2022, and the market estimates and forecasts are given from 2023 to 2028.
  • The scope for the medical plastics market is segmented into application and resin type.

CTLT Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Catalent, Inc. for Potential Securities Law Violations

Retrieved on: 
Wednesday, February 7, 2024

The plant is among those being acquired by Novo Nordisk in connection with the recently announced acquisition of Catalent by Novo Holdings.

Key Points: 
  • The plant is among those being acquired by Novo Nordisk in connection with the recently announced acquisition of Catalent by Novo Holdings.
  • On February 5, 2024, Catalent announced that it had agreed to be sold to Novo Holdings for $63.50 per share in cash.
  • As part of the transaction, Novo Nordisk will acquire three Catalent manufacturing facilities, including a plant located in Bloomington, Indiana.
  • As a result of the Bloomberg article, Catalent’s stock price dropped 2.27% in trading on February 6, 2024.

Kindeva Drug Delivery Launches New Analytical Services Global Business Unit

Retrieved on: 
Wednesday, January 31, 2024

Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, announced the expansion of its analytical services capabilities — launching a new global business unit offering integrated and stand-alone analytical support to the wider pharmaceutical, biopharmaceutical, and medical device sector.

Key Points: 
  • Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, announced the expansion of its analytical services capabilities — launching a new global business unit offering integrated and stand-alone analytical support to the wider pharmaceutical, biopharmaceutical, and medical device sector.
  • For more than half a century, Kindeva has developed significant knowledge, experience, and expertise working on inhaled, injectable, and transdermal drug delivery development programs and cGMP commercial supply.
  • Additionally, Kindeva has built deep expertise and capability in cGMP analytical services supporting its product development and supply partners.
  • In addition to increasing Kindeva’s global analytical footprint, Kindeva’s recently opened 32,000-square-foot state-of-the-art laboratories in Woodbury, Minnesota, will serve as the central hub for its expanded suite of stand-alone analytical services.

SyBridge Technologies to Participate in MD&M West

Retrieved on: 
Thursday, February 1, 2024

ITASCA, Ill., Feb. 1, 2024 /PRNewswire/ -- SyBridge Technologies, a global leader in design, tooling, and manufacturing, today announced that they will be participating at MD&M West to showcase its unparalleled ability to support every stage of the medical device lifecycle, from concept to product launch.

Key Points: 
  • ITASCA, Ill., Feb. 1, 2024 /PRNewswire/ -- SyBridge Technologies, a global leader in design, tooling, and manufacturing, today announced that they will be participating at MD&M West to showcase its unparalleled ability to support every stage of the medical device lifecycle, from concept to product launch.
  • Notably, SyBridge VP of Innovation, Research & Development Dr. Charlie Wood will be introducing the MD&M West keynote panel with a focus on Terrestrial Innovations in Quality Assurance for Space-Age Product.
  • MD&M West is the perfect stage to highlight how SyBridge is not just shaping the present, but propelling the industry towards a more efficient, innovative, and limitless future," says Dr. Charlie Wood, VP of Innovation, Research & Development at SyBridge Technologies.
  • MD&M West participants can visit SyBridge at booth #3943, where the company will be showcasing how it is pushing the boundaries of what is possible, ensuring exceptional precision, supporting greater manufacturing output, and helping brands reduce their overall costs.

EQS-News: SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory

Retrieved on: 
Tuesday, January 30, 2024

“With our 2023 results, we have delivered on all our targets and have proven that SCHOTT Pharma is a highly profitable business.

Key Points: 
  • “With our 2023 results, we have delivered on all our targets and have proven that SCHOTT Pharma is a highly profitable business.
  • We will continue to benefit from key pharma trends and the overall market growth for injectable drugs”, said Almuth Steinkühler, CFO of SCHOTT Pharma.
  • In 2023, SCHOTT Pharma continued to deliver on its strategy and achieved several milestones along the pillars expansion and innovation.
  • On the innovation side, SCHOTT Pharma successfully introduced two leading innovations to the market that serve the pharma megatrends Glucagon-like peptide-1 (GLP-1) and mRNA.

Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems

Retrieved on: 
Thursday, January 18, 2024

The LOI was inked on January 16 and will be celebrated at the upcoming Pharmapack 2024 event in Paris later in the month.

Key Points: 
  • The LOI was inked on January 16 and will be celebrated at the upcoming Pharmapack 2024 event in Paris later in the month.
  • “This agreement would be very beneficial for both companies.”
    Sharps Technology specializes in the development and manufacturing of innovative drug delivery systems.
  • This would open up a completely new level of service to the market,” states Ben Scheu, Senior Director of Sales for Sharps Technology.
  • Following the execution of a definitive sales and marketing cooperation agreement, Sharps and Roncadelle intend to collaborate on the development of new drug delivery products.

Emerging Trends in the Medical Refrigerators Industry, 2023-2028: Global Analysis Featuring Profiles of Leading Players Including Thermo Fisher, Blue Star, and Standex International Corporation - ResearchAndMarkets.com

Retrieved on: 
Monday, January 29, 2024

As a result, there is a rising need for medical refrigerators with sophisticated features including temperature, humidity, and alarm controls.

Key Points: 
  • As a result, there is a rising need for medical refrigerators with sophisticated features including temperature, humidity, and alarm controls.
  • Therefore, the burgeoning prevalence of chronic diseases has led to a greater focus on medical refrigerators, thus, boosting the overall market growth.
  • By Design Type: The report identifies four segments on the basis of design type: Countertop Medical Refrigerators, Undercounter Medical Refrigerators, Explosion-Proof Refrigerators, and Flammable Material Storage Medical Refrigerators.
  • The global medical refrigerators market is highly competitive and fragmented, with several players operating on a regional and global scale.